SkyCell forges new partnership with Marken
SkyCell is proud to announce its latest partnership with Marken, the clinical trials logistics subsidiary of UPS Healthcare, that specializes in providing global supply chain solutions from clinical to commercial. The collaboration will provide Marken with SkyCell containers to ship critical and temperature-sensitive drugs worldwide.
The new Marken Monarch hybrid container will be represented by two different SkyCell containers – the 1500DF Euro Max and the 1500X. The 1500DF Euro Max provides up to 300h of temperature stability for frozen goods (-60°C to -80°C). The 1500X has an independent runtime of up to 270h for COL goods (+2°C to +8°C) and CRT goods (+15°C to +25°C), with the added ability to recharge containers in transit. The containers are 34.1 percent lighter than comparable containers and with their long runtime are able to transport delicate products for clinical trials anywhere around the world.
The clinical trials supply chain is complex. With the high value of goods and the time critical nature of shipments, any risk of deviations can result in delays in releasing life-saving drugs to the market.
SkyCell has grown in tandem with our partners over the past decade. Our extensive network means that our containers reach all corners of the globe on over 400 individual lanes worldwide. This new partnership with Marken means that more SkyCell hybrid containers will be safely transporting valuable pharmaceutical products around the world than ever before.
“SkyCell is excited to partner with Marken as we share a common vision of establishing the highest standards for safe and sustainable pharmaceutical transport. This collaboration empowers SkyCell to leverage its cutting-edge technology and innovative solutions within the vital domain of clinical trials, further facilitating the secure distribution of sensitive and valuable pharmaceutical products. SkyCell looks forward, together with Marken, to advancing the standards of shipping in the pharmaceutical transport industry.”
The partnership between SkyCell and Marken represents a significant advancement in clinical trials logistics. By combining their expertise and resources, the two companies aim to optimize the transportation process, ensuring the safe and efficient delivery of critical drugs worldwide. This collaboration will contribute to the advancement of the clinical trials supply chain and ultimately benefit patients around the world.